薬物スクリーニングの市場規模、シェア、動向、予測：製品・サービス、サンプルタイプ、エンドユーザー、地域別、2025年～2033年

薬物スクリーニングの世界市場規模は2024年に68億7,000万米ドルとなりました。今後、2033年には120億3,000万米ドルに達し、2025年から2033年にかけて6.37%のCAGRを示すと推定されます。現在市場を独占しているのは北米で、2024年の市場シェアは51％を超えます。北米地域の成長の原動力は、厳しい職場規制、高度な検査技術、薬物乱用意識の高まりです。

薬物スクリーニング市場分析：

主な市場促進要因：薬物スクリーニングは正確で自発的に結果が得られるため、需要が増加しており、これが主に市場成長の原動力となっています。さらに、世界中で薬物乱用のケースが増加していることも、世界市場を後押ししています。

主な市場動向：自動化、人工知能（AI）、分子診断などの先端技術を薬物スクリーニング検査に統合することで、ワークフローを合理化し、人的ミスを減らし、検査を強化することが、重要な主要動向の1つとして作用し、市場の成長を後押ししています。

競合情勢：薬物スクリーニング市場の主要企業には、Abbott Laboratories、Alfa Scientific Designs Inc.、Bio-Rad Laboratories Inc.、Dragerwerk AG &Co.KGaA、Laboratory Corporation of America Holdings、Lifeloc Technologies Inc.、Omega Laboratories Inc.、OraSure Technologies Inc.、Psychemedics Corporation、Quest Diagnostics Incorporated、Siemens AG、Thermo Fisher Scientific Inc.などが挙げられます。

地理的動向：報告書によると、北米は薬物スクリーニングの最大市場です。同地域の成長は、薬物乱用の深刻化、薬物ディーラーの増加、処方薬の闇販売の増加に起因しています。

課題と機会：薬物スクリーニング市場は、正確で信頼性の高い検査の開発、偽陽性・偽陰性の克服、サンプル採取と検査手順に関するプライバシーと倫理的懸念への対応に関するハードルに直面しています。ビジネスチャンスは、データ分析のためのAIや機械学習などの先進技術の統合や、便利で迅速なスクリーニング用途のためのポータブルおよびポイントオブケア検査機器の開発にあります。

薬物スクリーニング市場動向：

薬物・アルコール消費の増加

薬物消費の増加により、薬物スクリーニング製品の需要が増加しています。例えば、2023 European Drug Reportによると、欧州連合（EU）の成人約8,340万人（29%）が違法薬物を一度でも使用したことがあると報告されています。大麻は欧州で消費される主要な違法薬物であり、各国の調査によると、2022年には欧州成人の8％が使用していると推定されています。このように、多くの人口が薬物を消費しているため、個人の生活に影響を与え、薬物スクリーニングの需要が増加し、薬物スクリーニング市場の最近の価格を押し上げる可能性が高いです。さらに、薬物やアルコールの利用が増加し、治療の必要性が高まることで、病院における薬物スクリーニングの需要が高まると予想されています。例えば、GOV.UKが発表した国家統計によると、2023年12月には、病院での薬物スクリーニングの需要が増加する見込みです。UKが発表した国家統計によると、2023年12月、2022年4月から2023年3月までの間に、約29万635人の成人が薬物使用問題の支援を受けた。これは、前年の約28万9,215人と比べてわずかな増加です。さらに、同じ情報源によれば、2022年から2023年にかけて治療に入った成人の数は約13万7,749人で、前2年の13万490人、13万3,704人を上回っています。このような物質使用中の人々の大幅な増加は、薬物スクリーニング市場の需要を促進すると予想されます。

政府規制

さまざまな分野で薬物検査やアルコール検査が義務付けられている法律や規制がいくつかあり、こうした法律の施行が薬物検査製品や機器の需要を増大させています。例えば、2022年11月、連邦自動車運送安全局（FMCSA）は、薬物・アルコール検査要件の概要を示す更新を発表しました。これらの規制は、検査の対象となる個人、検査の頻度、検査のきっかけとなる状況を規定しています。さらに、雇用主やサービス代理店による薬物・アルコール検査の機密情報の使用や開示を制限することで、従業員のプライバシーを保護しています。規制の枠組み以外にも、各国の政府当局は重度の中毒者や薬物乱用に苦しむ人々を支援するためのイニシアチブを取っており、これが薬物スクリーニング市場シェアをさらに押し上げています。例えば、Nasha Mukt Bharat Abhiyaanはインド政府によるプログラムで、大衆に手を差し伸べ、意識向上プログラムのような様々な活動を通じて薬物乱用に関する意識を広めることを意図しています。同様に、カナダの政府当局も、薬物依存症患者が薬物乱用から抜け出せるよう、薬物対策プロジェクトに投資しています。例えば、カナダのアルバータ州にあるカルガリー・ジョン・ハワード協会では、薬物中毒によって学校中退の危機に直面している13歳から24歳の若者の支援に力を入れています。

検査技術の進歩

迅速検査キット、検査室ベースのアッセイ、ポイントオブケア機器など、薬物スクリーニング技術の継続的な進歩は、より迅速で正確、かつ費用対効果の高いスクリーニング・ソリューションを提供することで、市場の成長をさらに促進しています。さらに、薬物スクリーニング技術の継続的な改善により、精度と信頼性が向上し、偽陽性や偽陰性の可能性が減少しているため、検査結果に対する信頼性が確保され、確認検査の必要性が最小限に抑えられ、スクリーニング・プロセスが合理化され、コストが削減されています。例えば、2024年2月、モバイル・ヘルス社は、ニューヨークのクリニックで、雇用主が候補者を簡単にスクリーニングして雇用できる新しい迅速薬物検査サービスを導入しました。同様に、2023年10月、ProciseDx Inc.は、アダリムマブ（ヒュミラとバイオシミラーAmgevita）とインフリキシマブ（レミケードとバイオシミラーInflectraとRenflexis）の治療薬物モニタリング（TDM）検査の新規FDA許可を取得しました。Procise ADLおよびProcise IFXと呼ばれるこれらのアッセイは、これらの薬剤を服用中の炎症性腸疾患（IBD）患者におけるアダリムマブ（ADL）およびインフリキシマブ（IFX）の定量に使用されます。新しい薬物検査や機器の承認が増加することで、今後数年間の薬物スクリーニング市場の収益が促進されると予想されます。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の薬物スクリーニング市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品・サービス別

• 装置
  • 主要セグメント
    • 免疫測定分析装置
    • クロマトグラフィー機器
    • 呼気分析装置
• 迅速検査装置
  • 主要セグメント
    • 尿検査装置
    • 口腔液検査装置
• 消耗品
  • 主要セグメント
    • アッセイキット
    • サンプル収集カップ
    • キャリブレーターとコントロール
    • その他
• ラボサービス

第7章 市場内訳：サンプルタイプ別

• 尿サンプル
• 呼気サンプル
• 口腔液サンプル
• 毛髪サンプル
• その他

第8章 市場内訳：エンドユーザー別

• 病院
• 薬物検査ラボ
• 職場
• 薬物治療センター
• 疼痛管理センター
• 個人ユーザー
• 刑事司法制度と法執行機関

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Alfa Scientific Designs Inc.
  • Bio-Rad Laboratories Inc.
  • Dragerwerk AG & Co. KGaA
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies Inc.
  • Omega Laboratories Inc.
  • OraSure Technologies Inc.
  • Psychemedics Corporation
  • Quest Diagnostics Incorporated
  • Siemens AG
  • Thermo Fisher Scientific Inc.

List of Figures

• Figure 1: Global: Drug Screening Market: Major Drivers and Challenges
• Figure 2: Global: Drug Screening Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Drug Screening Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Drug Screening Market: Breakup by Product and Service (in %), 2024
• Figure 5: Global: Drug Screening Market: Breakup by Sample Type (in %), 2024
• Figure 6: Global: Drug Screening Market: Breakup by End User (in %), 2024
• Figure 7: Global: Drug Screening Market: Breakup by Region (in %), 2024
• Figure 8: Global: Drug Screening (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Drug Screening (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Drug Screening (Rapid Testing Devices) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Drug Screening (Rapid Testing Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Drug Screening (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Drug Screening (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Drug Screening (Laboratory Services) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Drug Screening (Laboratory Services) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Drug Screening (Urine Samples) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Drug Screening (Urine Samples) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Drug Screening (Breath Samples) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Drug Screening (Breath Samples) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Drug Screening (Oral Fluid Samples) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Drug Screening (Oral Fluid Samples) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Drug Screening (Hair Samples) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Drug Screening (Hair Samples) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Drug Screening (Other Sample Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Drug Screening (Other Sample Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Drug Screening (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Drug Screening (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Global: Drug Screening (Drug Testing Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Global: Drug Screening (Drug Testing Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Global: Drug Screening (Workplaces) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Global: Drug Screening (Workplaces) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Global: Drug Screening (Drug Treatment Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Global: Drug Screening (Drug Treatment Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Global: Drug Screening (Pain Management Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Global: Drug Screening (Pain Management Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Global: Drug Screening (Personal Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Global: Drug Screening (Personal Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Global: Drug Screening (Criminal Justice System and Law Enforcement Agencies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: North America: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: North America: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: United States: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: United States: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Canada: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Canada: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Asia-Pacific: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Asia-Pacific: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: China: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: China: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Japan: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Japan: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: India: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: India: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: South Korea: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: South Korea: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Australia: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Australia: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Indonesia: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Indonesia: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Others: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Others: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Europe: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Europe: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Germany: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Germany: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: France: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: France: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: United Kingdom: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: United Kingdom: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Italy: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Italy: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Spain: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Spain: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Russia: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Russia: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Others: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Others: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Latin America: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 79: Latin America: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 80: Brazil: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 81: Brazil: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 82: Mexico: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 83: Mexico: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 84: Others: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 85: Others: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 86: Middle East and Africa: Drug Screening Market: Sales Value (in Million USD), 2019 & 2024
• Figure 87: Middle East and Africa: Drug Screening Market: Breakup by Country (in %), 2024
• Figure 88: Middle East and Africa: Drug Screening Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 89: Global: Drug Screening Industry: SWOT Analysis
• Figure 90: Global: Drug Screening Industry: Value Chain Analysis
• Figure 91: Global: Drug Screening Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Drug Screening Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Drug Screening Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
• Table 3: Global: Drug Screening Market Forecast: Breakup by Sample Type (in Million USD), 2025-2033
• Table 4: Global: Drug Screening Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Drug Screening Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Drug Screening Market: Competitive Structure
• Table 7: Global: Drug Screening Market: Key Players

The global drug screening market size was valued at USD 6.87 Billion in 2024. Looking forward, it is estimated that the market to reach USD 12.03 Billion by 2033, exhibiting a CAGR of 6.37% from 2025-2033. North America currently dominates the market, holding a market share of over 51% in 2024. The growth of the North American region is driven by stringent workplace regulations, advanced testing technologies, and increased substance abuse awareness.

Drug Screening Market Analysis:

Major Market Drivers: Increasing demand for drug screening as it is accurate and provides spontaneous results is primarily driving the growth of the market. Furthermore, the rising cases of substance abuse around the world are also propelling the global market.

Key Market Trends: The integration of advanced technologies such as automation, artificial intelligence (AI), and molecular diagnostics with drug screening tests to streamline workflows, reduce human errors, and enhance testing is acting as one of the significant key trends, bolstering the market growth.

Competitive Landscape: Some of the leading drug screening market companies include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, and Thermo Fisher Scientific Inc., among others.

Geographical Trends: According to the report, North America is the largest market for drug screening. The growth of the region can be attributed to the escalating cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs.

Challenges and Opportunities: The drug screening market faces hurdles related to the development of accurate and reliable tests, overcoming false positives and negatives, and addressing privacy and ethical concerns regarding sample collection and testing procedures. Opportunities lie in the integration of advanced technologies such as AI and machine learning for data analysis and the development of portable and point-of-care testing devices for convenient and rapid screening applications.

Drug Screening Market Trends:

Rise in Drug and Alcohol Consumption

The increasing consumption of drugs is resulting in an increased demand for drug-screening products. For instance, according to the 2023 European Drug Report, approximately 83.4 million adults (29%) in the European Union have reportedly used illicit drugs at least once. Cannabis is the predominant illicit drug consumed in Europe, with an estimated 8% of European adults using it in 2022, based on national surveys. Thus, a high number of the population consumes drugs, which impacts the lives of individuals and is likely to increase demand for drug screening, thereby bolstering the drug screening market's recent price. Additionally, the rising utilization of drugs and alcohol, along with the need for treatment, is anticipated to drive up the demand for drug screening in hospitals. For instance, as per National statistics published by GOV. UK, in December 2023, between April 2022 and March 2023, around 290,635 adults received support for substance use issues. This is a small rise compared to the previous year, around 289,215. Moreover, the same source stated that the number of adults entering treatment from 2022 to 2023 was approx. 137,749, which is higher than the previous two years' figures of 130,490 and 133,704. Such a significant rise in the number of people undergoing substance use is anticipated to propel the drug screening market demand.

Government Regulations

Several laws and regulations mandate drug and alcohol testing in various sectors, and the implementation of such laws is augmenting the demand for drug-screening products and devices. For instance, in November 2022, the Federal Motor Carrier Safety Administration (FMCSA) released updates outlining the drug and alcohol testing requirements. These regulations specify the individuals subject to testing, the frequency of testing, and the circumstances triggering testing. Additionally, the regulations safeguard employee privacy by limiting the use and disclosure of sensitive drug and alcohol testing information by employers and service agents. Besides the regulatory framework, government authorities of various nations are also taking initiatives to help severe addicts and individuals suffering from drug abuse, which is further propelling the drug screening market share. For instance, Nasha Mukt Bharat Abhiyaan is a program by the Indian Government that intends to reach out to the masses and spread awareness about substance abuse through various activities like awareness generation programs. Similarly, the government authorities of Canada are also investing in anti-drug strategy projects to help people with addiction come out of substance abuse. For example, the Calgary John Howard Society in Alberta, Canada, focuses on assisting youths aged 13 to 24 who face the risk of school dropout due to drug addiction.

Advancements in Testing Technologies

Ongoing advancements in drug screening technologies, such as rapid testing kits, laboratory-based assays, and point-of-care devices, are further driving the market growth by offering faster, more accurate, and cost-effective screening solutions. Moreover, the continuous improvement of drug screening technologies is resulting in enhanced accuracy and reliability and reduced likelihood of false positives or false negatives, ensuring confidence in test results and minimizing the need for confirmatory testing, thereby streamlining the screening process and reducing costs. For instance, in February 2024, Mobile Health introduced a new rapid drug testing service in New York clinics for employers to screen and hire candidates easily. Similarly, in October 2023, ProciseDx Inc. received de novo FDA clearance for the therapeutic drug monitoring (TDM) tests for adalimumab (Humira and biosimilar Amgevita) and infliximab (Remicade and biosimilars Inflectra and Renflexis). These assays, called Procise ADL and Procise IFX, are used to quantify adalimumab (ADL) and infliximab (IFX) in patients suffering from inflammatory bowel diseases (IBD) who are taking these drugs. Increasing approval of new drug tests and instruments is anticipated to propel the drug screening market revenue in the coming years.

Global Drug Screening Industry Segmentation:

Breakup by Product and Service:

• Equipment
• Immunoassay Analyzers
• Chromatography Instruments
• Breath Analyzers
• Rapid Testing Devices
• Urine Testing Devices
• Oral Fluid Testing Devices
• Consumables
• Assay Kits
• Sample Collection Cups
• Calibrators and Controls
• Others
• Laboratory Services

Rapid testing devices represented the largest segment

The drug screening market report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.

Rapid drug screening test devices are portable, easy-to-use tools designed for quick detection of drugs in various sample types, such as urine, saliva, or blood. These devices offer several benefits, including rapid results within minutes, enabling on-the-spot decision-making in scenarios like workplace testing or roadside screening. Their simplicity allows for minimal training requirements, making them accessible to a wide range of users. Moreover, rapid tests are cost-effective, reducing the need for laboratory analysis and turnaround time. For instance, Drager, a German company based in Lubeck that makes breathing and protection equipment, gas detection and analysis systems, and non-invasive patient monitoring technologies, introduced a rapid test named DrugTest 5000. In this test, saliva samples can be analyzed immediately for an accurate result on the spot. Furthermore, rapid screening devices play a crucial role in emergencies, aiding in the quick identification of drug intoxication or overdose for prompt medical intervention.

Breakup by Sample Type:

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Others

Urine samples accounted for the largest market share

As per the drug screening market overview, urine sample drug testing offers several benefits, making it a preferred method over other sample types in many scenarios. Firstly, urine testing is non-invasive and relatively easy to collect, minimizing discomfort and ensuring employee cooperation. Secondly, urine samples can detect a wide range of drugs and their metabolites, providing comprehensive screening capabilities. Thirdly, urine testing is cost-effective and suitable for high-volume testing, making it practical for workplace screening programs. Furthermore, urine testing is capable of detecting recent drug use, making it suitable for detecting impairment in safety-sensitive industries. Lastly, this testing is less susceptible to adulteration or tampering compared to other sample types, ensuring the integrity and reliability of test results.

Breakup by End User:

• Hospitals
• Drug Testing Laboratories
• Workplaces
• Drug Treatment Centers
• Pain Management Centers
• Personal Users
• Criminal Justice System and Law Enforcement Agencies

Workplaces accounted for the largest market share

Drug screening tests in workplaces are conducted to detect the presence of drugs or alcohol in employees. These tests are typically performed as part of pre-employment screening, random testing, post-accident testing, or reasonable suspicion testing. The aim is to ensure a safe and productive work environment, minimize the risk of accidents and injuries, and deter substance abuse among employees.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America (the United States and Canada) was the largest market for drug screening

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening.

Some of the factors driving the North America drug screening market included the growing cases of substance abuse, the increasing number of drug dealers, and the rising black marketing of prescribed drugs. Moreover, drug screening market statistics by IMARC indicate that the growing substance abuse rates in the region are bolstering the need for drug screening. For instance, in February 2023, according to an article published by the Pennsylvania State University, around 63% of adults aged 18 years and above were reported to alcohol consumption in the United States in 2022. Among these, males (66%) had higher alcohol consumption as compared to females (61%). Thus, the large number of alcohol consumers raises the need for drug-testing products and services and is augmenting the market growth in North America. Moreover, the government authorities of North America are mandating drug screening tests in various sectors, which is further catalyzing the market growth. For instance, in May 2023, the United States Department of Transportation regulated the drug testing program by including oral fluid testing to improve safety and reduce the chances of cheating involved with urine drug tests.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include:

• Abbott Laboratories
• Alfa Scientific Designs Inc.
• Bio-Rad Laboratories Inc.
• Dragerwerk AG & Co. KGaA
• Laboratory Corporation of America Holdings
• Lifeloc Technologies Inc.
• Omega Laboratories Inc.
• OraSure Technologies Inc.
• Psychemedics Corporation
• Quest Diagnostics Incorporated
• Siemens AG
• Thermo Fisher Scientific Inc.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

Drug Screening Market Recent Developments:

March 2024: bioXcelerate, a new and innovative health data science division of Optima Partners Limited, revealed a groundbreaking AI tool, which is set to accelerate the process of identifying and developing new drugs. The tool, known as PleioGraph, can analyze complex medical data 100 times faster than existing state-of-the-art methods used to detect biological networks that explain disease risk and inform drug discovery.

December 2023: Quest Diagnostics, one of the leading providers of diagnostic information services, unveiled its new confirmatory testing service for novel psychoactive substances (NPS). The new panel, which tests for 88 compounds, covers a broad array of drug classes, such as designer opioids, designer benzodiazepines, designer stimulants, fentanyl analogs, synthetic cannabinoids, and other illicit additives.

October 2023: In India, Kerala police launched a rapid drug screening system that involves the utilization of a hand-held device, named the SoToxa Mobile Test System, and detects drug usage in 5 minutes.

Key Questions Answered in This Report

• 1.What is drug screening?
• 2.How big is the drug screening market?
• 3.What is the expected growth rate of the global drug screening market during 2025-2033?
• 4.What is the purpose of drug screening?
• 5.What are the different samples that can be used for drug screening?
• 6.What are the key factors driving the global drug screening market?
• 7.What is the leading segment of the global drug screening market based on product and service?
• 8.What is the leading segment of the global drug screening market based on sample type?
• 9.What is the leading segment of the global drug screening market based on end user?
• 10.What are the key regions in the global drug screening market?
• 11.Who are the key players/companies in the global drug screening market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Drug Screening Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product and Service

• 6.1 Equipment
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Immunoassay Analyzers
    • 6.1.2.2 Chromatography Instruments
    • 6.1.2.3 Breath Analyzers
  • 6.1.3 Market Forecast
• 6.2 Rapid Testing Devices
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Urine Testing Devices
    • 6.2.2.2 Oral Fluid Testing Devices
  • 6.2.3 Market Forecast
• 6.3 Consumables
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Assay Kits
    • 6.3.2.2 Sample Collection Cups
    • 6.3.2.3 Calibrators and Controls
    • 6.3.2.4 Others
  • 6.3.3 Market Forecast
• 6.4 Laboratory Services
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Sample Type

• 7.1 Urine Samples
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Breath Samples
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Oral Fluid Samples
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Hair Samples
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Drug Testing Laboratories
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Workplaces
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Drug Treatment Centers
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Pain Management Centers
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Personal Users
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Criminal Justice System and Law Enforcement Agencies
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Alfa Scientific Designs Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Bio-Rad Laboratories Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Dragerwerk AG & Co. KGaA
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Laboratory Corporation of America Holdings
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 Lifeloc Technologies Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Omega Laboratories Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 OraSure Technologies Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Psychemedics Corporation
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Quest Diagnostics Incorporated
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
  • 14.3.11 Siemens AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Thermo Fisher Scientific Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis